News Focus
News Focus
Followers 28
Posts 5148
Boards Moderated 0
Alias Born 05/24/2006

Re: DewDiligence post# 2147

Thursday, 03/26/2009 5:55:13 AM

Thursday, March 26, 2009 5:55:13 AM

Post# of 3595
Copaxone was approved as an NDA through 505(b) that is why the FDA accepted Sandoz’s ANDA for review. However, given its complexities, I don't believe the FDA will treat this other than a biologic drug - meaning full clinical trials to demonstrate safety and efficacy will be required. We need not further debate on that, just wait for the anticipated FoB legislation to pass.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent TEVA News